Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.39 |
| ▸ | NPC1 | O15118 | 6/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6704762 | 1.00 | RAB9A (0.39) | RAB9ANPC1CES2CES1DAO | |
| SCHEMBL2259958 | 0.86 | ALDH1A1 (0.37) | RAB9ANPC1CES2CES1DAO | |
| SCHEMBL2259960 | 0.86 | ALDH1A1 (0.37) | RAB9ANPC1CES2CES1DAO | |
| SCHEMBL7050654 | 0.83 | DAO (0.37) | RAB9ANPC1CES2CES1DAO | |
| SCHEMBL385065 | 0.83 | MAPT (0.43) | RAB9ANPC1CES2CES1DAO | |
| SCHEMBL385064 | 0.83 | MAPT (0.43) | RAB9ANPC1CES2CES1DAO | |
| SCHEMBL6704979 | 0.83 | DAO (0.37) | RAB9ANPC1CES2CES1DAO | |
| SCHEMBL1397229 | 0.83 | ALDH1A1 (0.46) | RAB9ANPC1PKMMAPTKMT2A | |
| SCHEMBL1397231 | 0.83 | ALDH1A1 (0.46) | RAB9ANPC1PKMMAPTKMT2A | |
| SCHEMBL6705023 | 0.82 | HDAC3 (0.38) | RAB9ANPC1PKMMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040013974-A1 | Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity | DIETLIKER KURT (CH) | 2004-01-22 | — | — | US | claimed |
| EP-0925529-B1 | ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY | CIBA SC HOLDING AG (CH) | 2003-04-16 | — | — | EP | claimed |
| CN-107809996-A | Multistage method caused by nitric oxide | BSN医疗有限公司 | 2018-03-16 | — | — | CN | disclosed |
| CN-107708647-A | Medical Bathing Equipment | BSN医疗有限公司 | 2018-02-16 | — | — | CN | disclosed |
| US-6770420-B2 | Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-08-03 | — | — | US | disclosed |
| US-20040013974-A1 | Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity | DIETLIKER KURT (CH) | 2004-01-22 | — | — | US | disclosed |
| EP-0925529-B1 | ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY | CIBA SC HOLDING AG (CH) | 2003-04-16 | — | — | EP | disclosed |
| EP-0925529-A1 | ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY | Ciba SC Holding AG (CH) | 1999-06-30 | — | — | EP | disclosed |
| WO-1998010335-A1 | ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040013974-A1 | Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity | SULT1E1, CCNT1, CCNE1 | RAB9A 4672/4885NPC1 4796/4885CES2 1409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.